Clinicians should consider sequencing risk variants for clotting problems to help tailor inflammatory bowel disease drug therapy and perioperative anticoagulation prophylaxis, new research suggests.
The study found that roughly 16% of patients with IBD have a genetically increased risk for thromboembolic disease (TED), with the risk as much as 43% higher than in the general population for some IBD patients (Gastroenterology 2021;160:771-780).